{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T03:23:42Z","timestamp":1791948222253,"version":"4.3.4"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2011,9,30]],"date-time":"2011-09-30T00:00:00Z","timestamp":1317340800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1007\/s11010-011-1085-x","type":"journal-article","created":{"date-parts":[[2011,9,29]],"date-time":"2011-09-29T06:43:32Z","timestamp":1317278612000},"page":"39-45","source":"Crossref","is-referenced-by-count":37,"title":["VPA inhibits breast cancer cell migration by specifically targeting HDAC2 and down-regulating Survivin"],"prefix":"10.1007","volume":"361","author":[{"given":"Lei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenlin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Leng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinhua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiuhong","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,9,30]]},"reference":[{"key":"1085_CR1","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1126\/science.281.5381.1322","volume":"281","author":"JM Adams","year":"1998","unstructured":"Adams JM, Cory S (1998) The Bcl-2 protein family: arbiters of cell survival. Science 281:1322\u20131326. doi: 10.1126\/science.281.5381.1322","journal-title":"Science"},{"key":"1085_CR2","doi-asserted-by":"crossref","first-page":"50402","DOI":"10.1074\/jbc.M307627200","volume":"278","author":"M Fornaro","year":"2003","unstructured":"Fornaro M, Plescia J, Chheang S et al (2003) Fibronectin protects prostate cancer cells from tumor necrosis factor-alpha-induced apoptosis via the AKT\/survivin pathway. J Biol Chem 278:50402\u201350411. doi: 10.1074\/jbc.M307627200","journal-title":"J Biol Chem"},{"key":"1085_CR3","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nrc1670","volume":"5","author":"B Weigelt","year":"2005","unstructured":"Weigelt B, Peterse JL, Van\u2019t Veer LJ (2005) Breast cancer metastasis: markers and models. Nat Rev Cancer 5:591\u2013602. doi: 10.1038\/nrc1670","journal-title":"Nat Rev Cancer"},{"key":"1085_CR4","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1586\/14737140.7.4.583","volume":"7","author":"D Marchion","year":"2007","unstructured":"Marchion D, M\u00fcnster P (2007) Development of histone deacetylase inhibitors for cancer treatment. Expert Rev Anticancer Ther 7:583\u2013598. doi: 10.1586\/14737140.7.4.583","journal-title":"Expert Rev Anticancer Ther"},{"key":"1085_CR5","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.canlet.2008.08.016","volume":"277","author":"O Witt","year":"2009","unstructured":"Witt O, Deubzer HE, Milde T et al (2009) HDAC family: what are the cancer relevant targets? Cancer Lett 277:8\u201321. doi: 10.1016\/j.canlet.2008.08.016","journal-title":"Cancer Lett"},{"key":"1085_CR6","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ccr.2009.11.021","volume":"17","author":"S Mehrotra","year":"2010","unstructured":"Mehrotra S, Languino LR, Raskett CM et al (2010) IAP regulation of metastasis. Cancer Cell 17:53\u201364. doi: 10.1016\/j.ccr.2009.11.021","journal-title":"Cancer Cell"},{"key":"1085_CR7","doi-asserted-by":"crossref","first-page":"5273","DOI":"10.1158\/0008-5472.CAN-07-6673","volume":"68","author":"CW Lee","year":"2008","unstructured":"Lee CW, Raskett CM, Prudovsky I et al (2008) Molecular dependence of estrogen receptor\u2013negative breast cancer on a notch-survivin signaling axis. Cancer Res 68:5273\u20135281. doi: 10.1158\/0008-5472.CAN-07-6673","journal-title":"Cancer Res"},{"key":"1085_CR8","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1158\/0008-5472.CAN-06-4397","volume":"67","author":"KL Harms","year":"2007","unstructured":"Harms KL, Chen X et al (2007) Histone deacetylase 2 modulates p53 transcriptional activities through regulation of p53-DNA binding activity. Cancer Res 67:3145\u20133152. doi: 10.1158\/0008-5472.CAN-06-4397","journal-title":"Cancer Res"},{"key":"1085_CR9","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/sj.onc.1209784","volume":"26","author":"F V\u00e9gran","year":"2007","unstructured":"V\u00e9gran F, Boidot R, Oudin C et al (2007) Association of p53 gene alterations with the expression of antiapoptotic survivin splice variants in breast cancer. Oncogene 26:290\u2013297. doi: 10.1038\/sj.onc.1209784","journal-title":"Oncogene"},{"key":"1085_CR10","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.eplepsyres.2003.09.008","volume":"57","author":"BE Gidal","year":"2003","unstructured":"Gidal BE, Sheth R, Parnell J et al (2003) Evaluation of VPA dose and concentration effects on lamotrigine pharmacokinetics: implications for conversion to lamotrigine monotherapy. Epilepsy Res 57:85\u201393. doi: 10.1016\/j.eplepsyres.2003.09.008","journal-title":"Epilepsy Res"},{"key":"1085_CR11","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.lungcan.2008.03.023","volume":"62","author":"GY Wang","year":"2008","unstructured":"Wang GY, Hu XH, Lu CQ et al (2008) Promoter-hypermethylation associated defective expression of E-cadherin in primary non-small cell lung cancer. Lung Cancer 62:162\u2013172. doi: 10.1016\/j.lungcan.2008.03.023","journal-title":"Lung Cancer"},{"key":"1085_CR12","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/sj.cdd.4401567","volume":"12","author":"BH Huang","year":"2005","unstructured":"Huang BH, Laban M, Leung CH et al (2005) Inhibition of histone deacetylase 2 increases apoptosis and p21Cip1\/WAF1 expression, independent of histone deacetylase 1. Cell Death Differ 12:395\u2013404. doi: 10.1038\/sj.cdd.4401567","journal-title":"Cell Death Differ"},{"key":"1085_CR13","doi-asserted-by":"crossref","first-page":"15605","DOI":"10.1074\/jbc.M505937200","volume":"281","author":"KH Song","year":"2006","unstructured":"Song KH, Park YY, Kee HJ et al (2006) Orphan nuclear receptor Nur77 induces zinc finger protein GIOT-1 gene expression, and GIOT-1 acts as a novel corepressor of orphan nuclear receptor SF-1 via recruitment of HDAC2. J Biol Chem 281:15605\u201315614. doi: 10.1074\/jbc.M505937200","journal-title":"J Biol Chem"},{"key":"1085_CR14","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.canlet.2007.10.006","volume":"259","author":"N Fortunati","year":"2008","unstructured":"Fortunati N, Bertino S, Costantino L et al (2008) Valproic acid is a selective anti-proliferative agent in estrogen-sensitive breast cancer cells. Cancer Lett 259:156\u2013164. doi: 10.1016\/j.canlet.2007.10.006","journal-title":"Cancer Lett"},{"key":"1085_CR15","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.ctrv.2009.05.003","volume":"35","author":"BM Ryan","year":"2009","unstructured":"Ryan BM, O\u2019Donovan N, Duffy MJ (2009) Survivin: a new target for anti-cancer therapy. Cancer Treat Rev 35:553\u2013562. doi: 10.1016\/j.ctrv.2009.05.003","journal-title":"Cancer Treat Rev"},{"issue":"9","key":"1085_CR16","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.4161\/cbt.7.9.6415","volume":"7","author":"XH Zhang","year":"2008","unstructured":"Zhang XH, Rao M, Loprieato JA et al (2008) Aurora A, aurora B and survivin are novel targets of transcriptional regulation by histone deacetylase inhibitors in non-small cell lung cancer. Cancer Biol Ther 7(9):1388\u20131397. doi: 10.4161\/cbt.7.9.6415","journal-title":"Cancer Biol Ther"},{"issue":"3","key":"1085_CR17","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/ijc.25367","volume":"128","author":"A Biran","year":"2011","unstructured":"Biran A, Brownstein M, Haklai R et al (2011) Downregulation of survivin and aurora A by histone deacetylase and RAS inhibitors: a new drug combination for cancer therapy. Int J Cancer 128(3):691\u2013701. doi: 10.1002\/ijc.25367","journal-title":"Int J Cancer"},{"key":"1085_CR18","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.1074\/jbc.M106643200","volume":"277","author":"WH Hoffman","year":"2002","unstructured":"Hoffman WH, Biade S, Zilfou JT et al (2002) Transcriptional repression of the anti-apoptotic survivin gene by wild type p53. J Biol Chem 277:3247\u20133257. doi: 10.1074\/jbc.M106643200","journal-title":"J Biol Chem"},{"key":"1085_CR19","first-page":"8664","volume":"61","author":"T Zhang","year":"2001","unstructured":"Zhang T, Otevrel T, Gao Z et al (2001) Evidence that APC regulates survivin expression: a possible mechanism contributing to the stem cell origin of colon cancer. Cancer Res 61:8664\u20138667","journal-title":"Cancer Res"},{"key":"1085_CR20","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S1535-6108(04)00114-X","volume":"5","author":"P Zhu","year":"2004","unstructured":"Zhu P, Martin E, Mengwasser J et al (2004) Induction of HDAC2 expression upon loss of APC in colorectal tumorigenesis. Cancer Cell 5:455\u2013463. doi: 10.1016\/S1535-6108(04)00114X","journal-title":"Cancer Cell"},{"key":"1085_CR21","doi-asserted-by":"crossref","first-page":"9047","DOI":"10.1158\/0008-5472.CAN-07-0312","volume":"67","author":"S Zimmermann","year":"2007","unstructured":"Zimmermann S, Kiefer F, Prudenziati M et al (2007) Reduced body size and decreased intestinal tumor rates in HDAC2-mutant mice. Cancer Res 67:9047\u20139054. doi: 10.1158\/0008-5472.CAN-07-0312","journal-title":"Cancer Res"},{"key":"1085_CR22","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1056\/NEJMsr070105","volume":"356","author":"PM Ravdin","year":"2007","unstructured":"Ravdin PM, Cronin KA, Howlader N et al (2007) The decrease in breast-cancer incidence in 2003 in the United States. N Engl J Med 356:1670\u20131674. doi: 10.1056\/NEJMsr070105","journal-title":"N Engl J Med"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-011-1085-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11010-011-1085-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-011-1085-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T02:14:56Z","timestamp":1559355296000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11010-011-1085-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,30]]},"references-count":22,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["1085"],"URL":"https:\/\/doi.org\/10.1007\/s11010-011-1085-x","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,30]]}}}